SS

Sukhdev Singh

Active Director Director DIN 06874414
DIN 06874414 First appointment Jun 2014 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2014
Shareholding value •••• Premium profile

About Sukhdev Singh

Data last updated:

Sukhdev Singh is a Director at Velens Pharmaceuticals Private Limited (since 2014). The company operates in Chemicals. Velens Pharmaceuticals Private Limited reported revenue of ₹60.8 Lakh (FY 2025).

DIN 06874414
Primary Designation Director
Industry Chemicals
First Appointment 09 Jun 2014
Oldest Company Age 12 yrs
Largest company Velens Pharmaceuticals Private Limited · ₹60.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Jun 20142014₹60.8 Lakh (FY 2025)Active

Board colleagues of Sukhdev Singh

NameDINCompanyDesignation
Amit Kumar Pandey06874409Velens Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Velens Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sukhdev Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sukhdev Singh

Sukhdev Singh currently holds 1 directorship: Velens Pharmaceuticals Private Limited (Director, since 09 Jun 2014, revenue ₹60.8 Lakh (FY 2025)).

Sukhdev Singh was first appointed on 09 Jun 2014 as Director at Velens Pharmaceuticals Private Limited.

The current boards of Sukhdev Singh's companies include Amit Kumar Pandey (Velens Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available